S100A8 and cancer: S100A8 did not affect the percentage or absolute numbers of CD8 T cells in lungs or spleens from cancer-bearing mice, although it reduced total T cell and DNT cell infiltration in lungs from control mice (p < 0.05) (Supplementary Table 3).